You are here
Publications: 2014 - 2021
New publications, April 2020 onwards
[*COVID-19] Skirrow H, Barnett, S, Bell S, Riaposova L, Mounier-Jack S, Kampmann B, & Holder B. 2022 Jan. Women’s views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: A multi-methods study in the UK. BMC Pregnancy Childbirth. 22(1):33.
Deal A, Halliday R, Crawshaw A F, Hayward S, Burnard A, Rustage K, Carter J, Mehrotra A, Knights F, Campos-Matos I, Majeed A, Friedland JS, Edelstein M, Mounier-Jack S, Hargreaves S, 2021 Dec Migration and outbreaks of vaccine-preventable disease in Europe: a systematic review. The Lancet Infectious Diseases, 21 (12) e387-e398
Skirrow H, Barnett, S, Bell S., Mounier-Jack S, Kampmann B, & Holder B. 2021 Sept. Women’s views and experiences of accessing vaccination in pregnancy during the COVID-19 pandemic: A multi-methods study in the United Kingdom. MedRxiv, 2021.09.14.21263505.
[*COVID-19] Kasstan B, Mounier-Jack S, Letley L, Gaskell K. M, Roberts C. H, Stone N. R. H, Lal S, Eggo R. M, Marks M, & Chantler T. 2021 Sept. Localising Vaccination Services: Qualitative Insights on an Orthodox Jewish Collaboration with Public health during the UK coronavirus Vaccine Programme. MedRxiv, 2021.09.10.21263372.
[*COVID-19] Williamson EJ, McDonald H et al. 2021 Jul. Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform BMJ 2021;374:n1592. An easy read summary of this research is also available.
[*COVID-19] Bell S, Clarke, R. M., Ismail, S. A., Ojo-Aromokudu, O., Naqvi H, Coghill Y, Donovan H, Letley L, Paterson P, & Mounier-Jack S.2021 Apr 22. COVID-19 vaccination beliefs, attitudes, and behaviours among health and social care workers in the UK: a mixed-methods study MedRxiv, 2021.04.23.21255971.
[*COVID-19] Paterson P, 2021 Apr 16. How will covid-19 vaccine safety concerns impact vaccine confidence? Blog BMJ opinion
[*COVID-19] Sandmann F, Davies NG, CMMID COVID-19 working group, Vassall A, Edmunds WJ, Jit M. 2021 Mar 18 The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: transmission model-based future scenario analysis and economic evaluation. Lancet Infectious Diseases 2021; in press.
[*COVID-19] Davies NG, Jarvis CI et al., 2021 Mar 15. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7, Nature, 593, 270-274.
[*COVID-19] Forbes H, Morton CE, Bacon S, McDonald HI et al., 2021 Mar 18. Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England, BMJ, 372:n628.
[*COVID-19] Ladhani SN, Baawuah F, Beckmann J, Okike IO, et al. 2021 Mar 16. SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study. Lancet Child Adolesc Health :S2352-4642(21)00061-4.
[*COVID-19] Walker JL, Grint DJ, Strongman H, Eggo RM, Peppa M et al., 2021 Mar 11. UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records, BMC Public Health, 21(1):484.
[*COVID-19] Quilty BJ, Clifford S, Hellewell J, Russell TW, Kucharski AJ, Flasche S, Edmunds WJ; Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group. 2021 Mar 6. Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study. Lancet Public Health, (3):e175-e183.
[*COVID-19] Davies NG, Abbott S, Barnard RC et al., 2021 Mar 3. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England, Science, 372 (6538) eabg3055.
[*COVID-19] Grint DJ, Wing K, Williamson E, McDonald HI et al., 2021 March. Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February, Eurosurveillance, 26(11).
Jit M, Prem K, Benard E, Brisson M. 2021 Mar. From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness. Prev Med.144:106354
[*COVID-19] McCarthy CV, Sandmann F, Jit M; CMMID COVID-19 Working Group, 2021 Feb 19. Global and national estimates of the number of healthcare workers at high risk of SARS-CoV-2 infection, J Hosp Infect, S0195-6701(21)00071-2.
[*COVID-19] Jarvis CI, Gimma A, van Zandvoort K, Wong KLM; CMMID COVID-19 working group, Edmunds WJ. 2021 Feb 19. The impact of local and national restrictions in response to COVID-19 on social contacts in England: a longitudinal natural experiment. BMC Medicine; 19(1):52.
Karafillakis E, Martin S, Simas C, Olsson K, Takacs J, Dada S, Larson H. 2021. Methods for Social Media Monitoring Related to Vaccination: Systematic Scoping Review. JMIR Public Health and Surveillance, 7 (2). e17149-e17149. ISSN 2369-2960
[*COVID-19] Russell TW, Wu JT, Clifford S, Edmunds WJ, Kucharski AJ, Jit M; Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group, 2021 Jan 6. Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study. Lancet Public Health.(1):e12-e20.
[*COVID-19] Rentsch CT, DeVito NJ, MacKenna B et al., 2021 Jan,. Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform, Lancet Rheumatol, 3(1):e19-e27.
[*COVID-19] Bhaskaran K, Rentsch CT, MacKenna B et al., 2021 Jan. HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform, Lancet HIV, 8(1):e24-e32.
[*COVID-19] Wong AY, MacKenna B, Morton CE et al., 2021 Jan 21. Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts, Ann Rheum Dis., annrheumdis-2020-219517.
Davidson J, Banerjee A, Mathur R et al. 2021. Ethnic differences in the incidence of clinically diagnosed influenza: an England population-based cohort study 2008-2018 [version 1; peer review: 1 approved, 1 approved with reservations]. Wellcome Open Res, 6:49
HJ Forbes, K Bhaskaran, D Grint, et al. 2021. Incidence of acute complications of herpes zoster among immunocompetent adults in England: a matched cohort study using routine health data. Br J Dermatol. (online first)
[*COVID-19] Davies NG, Barnard RC, Jarvis CI, Russell TW, Semple MG, Jit M, Edmunds WJ; Centre for Mathematical Modelling of Infectious Diseases COVID-19 Working Group; ISARIC4C investigators. 2020 Dec 23. Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study. Lancet Infect Dis :S1473-3099(20)30984-1.
[*COVID-19] Sandmann FG, White PJ, Ramsay M, Jit M. 2020 Dec 15. Optimizing Benefits of Testing Key Workers for Infection with SARS-CoV-2: A Mathematical Modeling Analysis. Clin Infect Dis., 71(12):3196-3203.
[*COVID-19] Williamson EJ, Tazare J, Bhaskaran K, Walker AJ, McDonald HI, et al. 2020. Study protocol: Comparison of different risk prediction modelling approaches for COVID-19 related death using the OpenSAFELY platform [version 1; peer review: 1 approved]. Wellcome Open Res, 5:243
[*COVID-19] Carreira H, Strongman H, Peppa M, McDonald HI et al., 2020 Nov 30. Prevalence of COVID-19-related risk factors and risk of severe influenza outcomes in cancer survivors: A matched cohort study using linked English electronic health records data, EClinicalMedicine, 29-30:100656.
[*COVID-19] Schultze A, Walker AJ, MacKenna B et al., 2020 Nov. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform, Lancet Respir Med, 8(11):1106-1120.
[*COVID-19] Bell S, Clarke R, Mounier-Jack S, Walker J, Paterson P. 2020 Nov 17. Parent's and guardian's views on the acceptability of a future Covid-19 vaccine: a multi-methods study in England. Vaccine, 38 (49).
Luyten J, van Hoek AJ. 2020 Nov 13. Integrating alternative social value judgments into cost-effectiveness analysis of vaccines: an application to varicella-zoster virus vaccination. Value in Health, 24 (1).
Fisher H, Audrey S, Chantler T, Finn A, Letley L, Mounier-Jack S, Thomas C, Yates J, Hickman M. 2020 Nov 4. Co-production of an educational package for the universal human papillomavirus (HPV) vaccination programme tailored for schools with low uptake: a participatory study protocol. BMJ Open, 10(11):e039029.
Chantler T, Pringle E, Bell S, Cooper R, Edmundson E, Nielsen H, Roberts S, Edelstein M, Mounier-Jack S. 2020 Nov 3. Does electronic consent improve the logistics and uptake of HPV vaccination in adolescent girls? A mixed methods theory informed evaluation of an intervention. BMJ Open, 10 (11).
[*COVID-19] Firth JA, Hellewell J, Klepac P, Kissler S; CMMID COVID-19 Working Group, Kucharski AJ, Spurgin LG. 2020 Oct. Using a real-world network to model localized COVID-19 control strategies. Nature Medicine 2020; 26(10):1616-1622.
[*COVID-19] Russell TW, Golding N, Hellewell J, Abbott S, Wright L, Pearson CAB, van Zandvoort K, Jarvis CI, Gibbs H, Liu Y, Eggo RM, Edmunds WJ, Kucharski AJ, CMMID COVID-19 working group. 2020 Oct. Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections. BMC Medicine; 18(1):332.
Figueiredo A., Simas S, Karafilakis E, Paterson P, Larson H. 2020 Sept 10. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. The Lancet, 396 (10255): 898-908.
[*COVID-19] Leng T, White C, Hilton J, Kucharski A, Pellis L, Stage H, Davies NG et al., 2020 Sep 10. The effectiveness of social bubbles as part of a Covid-19 lockdown exit strategy, a modelling study, Wellcome Open Res, 0.35625.
[*COVID-19] Forman R, Anderson M, Jit M, Mossialos E. 2020 Sep 3. Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines. Vaccine;38(39):6075-6077.
[*COVID-19] Emery JC, Russell TW, Liu Y, Hellewell J, Pearson CA, CMMID COVID-19 Working Group, Knight GM, Eggo RM, Kucharski AJ, Funk S, Flasche S, Houben RM. 2020 August. The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship. Elife; 9:e58699.
Martin S, Kilich E, Dada S, Kummervold PE, Denny C, Paterson P, Larson HJ. 2020 Aug. "Vaccines for pregnant women…?! Absurd" - Mapping maternal vaccination discourse and stance on social media over six months. Vaccine, 38 6627-6637
Kilich E, Dada S, Francis MR, Tazare J, Chico RM, Paterson P, et al. 2020 Jul. Factors that influence vaccination decision-making among pregnant women: A systematic review and metaanalysis. PLoS ONE 15(7): e0234827
[*COVID-19] Williamson E J, Walker A J, Bhaskaran K, Bacon S, Bates C,...McDonald H, ...Smeeth L, et al. 2020 July 8. Factors associated with COVID-19-related death using OpenSAFELY. Nature, 584.
[*COVID-19] Privor-Dumm LA, Poland GA, Barratt J, Durrheim DN, Deloria Knoll M, Vasudevan P, Jit M, Bonvehí PE, Bonanni P; International Council on Adult Immunization. 2020 Jul 3. A global agenda for older adult immunization in the COVID-19 era: A roadmap for action. Vaccine, S0264-410X(20)30885-9.
[*COVID-19] Kucharski AJ, Klepac P, Conlan AJK, Kissler SM, Tang ML, Fry H, Gog JR, Edmunds WJ; CMMID COVID-19 working group. 2020 Jun 15. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. Lancet Infect Dis, S1473-3099(20)30457-6.
Peppa M, Thomas SL, Minassian C, Walker JL, McDonald HI, Andrews NJ, Kempley ST, Mangtani P. 2020 23 June Seasonal Influenza Vaccination During Pregnancy and the Risk of Major Congenital Malformations in Live-born Infants: A 2010–2016 Historical Cohort Study, Clinical Infectious Diseases.
[*COVID-19] Davies NG, Klepac P, Liu Y et al. 2020 June 16. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nature Medicine.
[*COVID-19] Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HHX. 2020 June 15. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Global Health, Online first.
[*COVID-19] Davies NG, Kucharski AJ, Eggo RM, Gimma A, Edmunds WJ, CMMID WG. 2020 June 2. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study. Lancet Public Health, Online first.
Jarvis CI, Van Zandvoort K, Gimma A, Prem K; CMMID COVID-19 working group, Klepac P, Rubin GJ, Edmunds WJ. 2020 May. Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK. BMC Medicine, 18(1):124.
Bell S, Chantler T, Paterson P, Mounier-Jack S. 2020 May 27. Is flu vaccination opt-out feasible? Evidence from vaccination programme implementers and managers in the English National Health Service. Vaccine, 38(26):4183-4190.
[*COVID-19] McDonald H, Tessier E, White J, Woodruff M, Knowles C, Bates C, Parry J, Walker JL, Scott JAG, Smeeth L, Yarwood J, Ramsay M, Edelstein M. 2020 May 14. Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020 Eurosurveillance, 25 (19).
[*COVID-19] Jit M, Jombart T, Nightingale ES, Endo A, Abbot S, CMMID WG, Edmunds WJ. 2020 May 7. Estimating number of cases and spread of Coronavirus disease 2019 (COVID-19) in the United Kingdom using critical care admissions, February to March 2020. Eurosurveillance, 25(18):pii=2000632.
Bell S, Saliba V, Evans G, et al. 2020 Apr 29. Responding to measles outbreaks in underserved Roma and Romanian populations in England: the critical role of community understanding and engagement. Epidemiology and Infection, 45292.
[*COVID-19] Russell TW, Hellewell J, Jarvis CI, van Zandvoort K, Abbott S, Ratnayake R, CMMID Covid-Working Group, Flasche S, Eggo RM, Edmunds WJ, Kucharski AJ. 2020 Mar. Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020. Eurosurveillance; 25(12):2000256.
[*COVID-19] Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S, Eggo R on behalf of the Centre for Mathematical Modelling of Infectious Diseases COVID-19 working group. 2020 Mar. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Inf Dis, 20(5):553-558.
[*COVID-19] Quilty BJ, Clifford S, Flasche S, Eggo RM; CMMID nCoV working group. 2020 Feb. Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV). Euro Surveillance, 25(5):2000080.
HPRU 1: April 2014 - March 2020
Andrews N, Stowe J, Thomas SL, Walker JL, Miller E. 2019 Jul 30. The risk of non-specific hospitalised infections following MMR vaccination given with and without inactivated vaccines in the second year of life. Comparative self-controlled case-series study in England. Vaccine, pii: S0264-410X(19)30967-3.
Atchison C J, Stowe J, Andrews N, Collins D, Allen DJ, Nawaz S, Borwn D, Ramsay M E, Ladhani S. 2016 Jan 15. Rapid Declines in Age Group–Specific Rotavirus Infection and Acute Gastroenteritis Among Vaccinated and Unvaccinated Individuals Within 1 Year of Rotavirus Vaccine Introduction in England and Wales.. J Infect Dis., 213(2):243-9.
Atkins K, Fitzpatrick M, Galvani A, Townsend J. 2016 Jun 15. Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States. Am J Epidemiol, 183(12):1159-70.
Atkins K, Flasche S. 2018 Mar. Vaccination to reduce antimicrobial resistance. Lancet Global Health, 6(3):e252.
Atkins K, Lafferty E, Deeny S, Davies N, Robotham J, Jit M. 2018 Jun. Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance. Lancet Infect Dis, 18(6):e204-e213.
Atkins K, Pandey A, Wenzel N, Skrip L, Yamin D, Nyenswah T, Falla M, Bawo L, Medlock M, Altice F, Townsend J, Ndeffo-Mbah M, Galvani A. 2016 Apr. Retrospective Analysis of the 2014-2015 Ebola Epidemic in Liberia. Am J Trop Med Hyg, 94(4):833-9.
Atkins KE, Lafferty EI, Deeny SR, Davies NG, Robotham JV, Jit M.. 2018 Jun. Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance.. Lancet Infect Dis, 18(6):e204-e213.
Atkins KE, Lipsitch M. 2018 Nov. Can antibotic resistance be reduced by vaccinating against respiratory disease?. Lancet Respiratory Medicine, 6(11):820-821.
Atkins KE, Wenzel NS, Ndeffo-Mbah M, Altice FL, Townsend JP, Galvani AP. 2015 Mar 16. Under-reporting and case fatality estimates for emerging epidemics. BMJ, 2015;350:h1115.
Atkins, K. van Hoek, A J, Watson C, Baguelin, M, Choga L, Patel A, Raj T, Jit M, Griffiths U. 2016 Feb 16. Seasonal influenza vaccination delivery through community pharmacists in England: evaluation of the London pilot.. BMJ Open, 6(2):e009739.
Baguelin M, Camacho A, Flasche S, Edmunds WJ. 2015 Oct 13. Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study. BMC Med, 13:236.
Baguelin M, Edmunds WJ. 2020 Mar 12. Childhood vaccination against seasonal influenza - is there a risk of undesirable outcomes? BMC Medicine, 18(1):37.
Bate J, Baker S, Breuer J, Chisholm JC, Gray J, Hambleton S, Houlton A, Jit M, Lowis S, Makin G, O'Sullivan C, Patel SR, Phillips R, Ransinghe N, Ramsay ME, Skinner R, Wheatley K, Heath PT. 2019 Jan. PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer. Arch Dis Child, 104(1):25-29.
Bell S, Edelstein M, Zatoński M, Ramsay M, Mounier-Jack S. 2019 Jul 9. I don't think anybody explained to me how it works': qualitative study exploring vaccination and primary health service access and uptake amongst Polish and Romanian communities in England.. BMJ Open, 9(7):e028228.
Bell S, Saliba V, Ramsay M, Mounier-Jack S. 2020 Mar 23. What have we learnt from measles outbreaks in 3 English cities? A qualitative exploration of factors influencing vaccination uptake in Romanian and Roma Romanian communities. BMC Public Health, 20, Article number: 381.
Bilcke J, Chapman R, Atchison C, Cromer D, Johnson H, Willem L, Cox M, Edmunds WJ, Jit M. 2015 Jan 26. Quantifying parameter and structural uncertainty of dynamic disease transmission models using MCMC: an application to rotavirus vaccination in England & Wales. Med Decis Making, 2015 Jul;35(5):633-47.
Bisset K, Paterson P. 2018 May 11. Strategies for increasing uptake of vaccination in pregnancy in high-income countries: A systematic review. Vaccine, 36(20):2751-2759.
Chantler T, Bell S, Saliba V, Heffernan C, Raj T, Ramsay M et al. 2019 Jan 17. Is partnership the answer? Delivering the national immunisation programme in the new English health system: a mixed methods study. BMC Public Health, 19(1): 83.
Chantler T, Karafillakis E, Wilson J. 2019 Jun. Vaccination: Is There a Place for Penalties for Non-compliance?. Appl Health Econ Health Policy, 17(3):265-271.
Chantler T, Letley L, Paterson P, Yarwood J, Saliba V, Mounier-Jack S. 2019 Jul 24. Optimising informed consent in school-based adolescent vaccination programmes in England: A multiple methods analysis. Vaccine, pii: S0264-410X(19)30969-7.
Choi Y, Campbell H, Amirthalingam G, van Hoek A, Miller E. 2016 Sep 1. Investigating the pertussis resurgence in England and Wales, and options for future control. BMC Med, 14(1):121.
Chungman C, Davies N, Jit M, Atkins K. 2020 Jan. Effect of Pediatric Influenza Vaccination on Antibiotic Resistance, England and Wales. Emerging Infectious Diseases, 26(1):138-142.
Clarke RM, Sirota M, Paterson P. 2019 August 23. Do previously held vaccine attitudes dictate the extent and influence of vaccine information-seeking behavior during pregnancy? Human Vaccines & Immunotherapeutics, 15(9): 2081–2089.
Clarke RM, Paterson P, Sirota M. 2019 May 6. Determinants of satisfaction with information and additional information-seeking behaviour for the pertussis vaccination given during pregnancy. Vaccine, 37(20):2712-2720.
Coltart C, Edmunds W, Atkins K. 2017 May 26. The 2013–2016 Ebola epidemic: multidisciplinary success conceals a missed opportunity. Philos Trans R Soc Lond B Biol Sci., 372(1721). pii: 20160292.
Crocker-Buque T, Edelstein M, Mounier-Jack S. 2017 Jan. Interventions to reduce inequalities in vaccine uptake in children and adolescents aged <19 years: a systematic review. J Epidemiol Community Health, 71(1):87-97.
Crocker-Buque T, Edelstein M, Mounier-Jack S. 2018 Oct 22. A process evaluation of how the routine vaccination programme is implemented at GP practices in England. Implementation Science., 13(1).
Crocker-Buque T, Mohan K, Ramsay M, Edelstein M, Mounier-Jack S. 2019 Jun 14. What is the cost of delivering routine vaccinations at GP practices in England? A comparative time-driven activity-based costing analysis. Hum Vaccin Immunother., 1-8.
Crocker-Buque T, Mounier-Jack S. 2018 Dec 6. Vaccination in England: a review of why business as usual is not enough to maintain coverage. BMC Public Health, 18(1).
Cromer D, van Hoek A, Newall A, Pollard A, Jit M. 2017 Jul 31. Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England. Lancet Public Health, 2(8):e367-e374.
Davies NG, Flasche S, Jit M, Atkins KE. 2019 Jan 3. Within-host dynamics shape the coexistence of antibiotic-sensitive and resistant bacteria. Nature Ecology and Evolution, 3:440-449.
Edelstein M, Crocker-Buque T, Tsang C, Eugenio O, Hopson T, Pebody R et al. 2017 Sep 12. Extracting general practice data for timely vaccine coverage estimates: The England experience. Vaccine, 35(38):5110-5114.
Edwards A, Bedford H, Campbell H, Letley L, Paterson P, Pebody R et al. 2017 Oct 7. Promoting influenza vaccine for children. Practice Nursing, 28(10): 413-418.
Fernandes S, Jit M, Bozzani F, Griffiths U, Scott J, Burchett H. 2018 Apr 19. A bibliometric analysis of systematic reviews on vaccines and immunisation. Vaccine, 36(17):2254-2261.
Fitzpatrick M, Wenzel N , Scarpino S, Althouse B, Atkins K, Galvani Alison, Townsend J. 2016 Apr 14. Cost-effectiveness of next-generation vaccines: the case of pertussis.. Vaccine, 34(29):3405-11.
Flasche S, Atkins KE. 2018 Nov 1. Balancing benefits and risks of antibiotic use. Journal of Infectious Diseases, Volume 218, Issue 9, Pages 1351–1353.
Flasche S, van Hoek AJ,Goldblatt D, Edmunds WJ, O’Brien KL, Scott JAG, Miller E. 2015 Jun 9. The potential for reducing the number of pneumococcal conjugate vaccine doses while sustaining herd immunity. PLoS Med, 12(6).
Grint DJ, McDonald HI, Walker JL, et al. 2020 Jan 29. Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a UK-based observational cohort analysis. BMJ Open, 10:e034886.
Hargreaves S, Nellums LB, Ramsay M, Saliba V, Majeed A, Mounier-Jack S, Friedland JS. 2018 May 5. Who is responsible for the vaccination of migrants in Europe?. Lancet, 391(10132):1752-1754.
[*COVID-19] Hellewell J, Sun F et al. 2020 Apr 1. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Global Health, 8(4), e488 - e496.
Hodgson D, Atkins K, Baguelin M, Panovska-Griffiths J, Thorrington D, van Hoek AJ, Zhao H, Fragaszy E, Hayward A, Pebody R. 2019 Oct 18. Estimates for Quality of Life Loss due to RSV. Influenza Other Respir Viruses, 14(1):19-27.
Hobbelen P, Stowe J, Amirthalingam G, Miller L, van Hoek A. 2016 Sep. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013. J Infect, 73(3):241-53.
Hodgson D, Baguelin M, van Leeuwen E, Panovska-Griffiths J, Ramsay M, Pebody R, Atkins KE. 2017 Feb. Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis. Lancet Public Health, 2(2):e74-e81.
Jain A, van Hoek A, Boccia D, Thomas S. 2017 Apr 25. Lower vaccine uptake amongst older individuals living alone: A systematic review and meta-analysis of social determinants of vaccine uptake. Vaccine, 35(18):2315-2328.
Jain A, van Hoek A, Walker JL, Mathur R, Smeeth, Thomas SL. 2017 Nov 30. Identifying social factors amongst older individuals in linked electronic health records: An assessment in a population based study. PloS One, 12:e0189038.
Jain A, van Hoek AJ, Walker JL, Forbes HJ, Langan SM, Root A, Smeeth L, Thomas SL. 2018 Jun. Inequalities in zoster disease burden: a population-based cohort study to identify social determinants using linked data from the UK Clinical Practice Research Database.. Br J Dermatol, 178(6):1324-1330.
Jain A, Walker J, Mathur R, Forbes H, Langan S, Smeeth L, van Hoek A, Thomas S. 2018 Nov 15. Zoster vaccination inequalities: A population based cohort study using linked data from the UK Clinical Practice Research Datalink. PLOS ONE, 13(11), p.e0207183.
Jit M, Brisson M, Lapise J-F, Choi YH. 2015 Jan 7. Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model.. BMJ, 2015;350:g7584.
Jit M, Hutubessy R. 2016 Jan 30. Methodological challenges to economic evaluations of vaccines: is a common approach still possible?. Appl Health Econ Health Policy, 14(3):245-52.
Jit M, Mibei Walter. 2015 Jul 31. Discounting in the evaluation of the cost-effectiveness of a vaccination programme: a critical review. Vaccine, 33(32):3788-94.
Jit M, Ng DHL, Luangasanatip N, et al. 2020 Mar 6. Quantifying the economic cost of antibiotic resistance and the impact of related interventions: rapid methodological review, conceptual framework and recommendations for future studies. BMC Medicine, 18(1):38.
Jit M. 2018 Nov 9. MCDA from a health economics perspective: opportunities and pitfalls of extending economic evaluation to incorporate broader outcomes. Cost Eff Resour Alloc, 16(Suppl 1): 45.
Karafillakis E, Larson H. 2017 Sep 5. The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations. Vaccine, 35(37):4840-4850.
Kennedy I, van Hoek A, Ribeiro S, Christensen H, Edmunds W, Ramsay M et al. 2017 May 18. Short-term changes in the health state of children with group B meningococcal disease: A prospective, national cohort study. PloS One, 12(5):e0177082.
Leite A, Andrews N, Thomas S. 2016 Mar. Near real-time vaccine safety surveillance using leectronic health records - a systematic reviews of the application of statistical methods. Pharmacoepidemiol Drug Saf., 25(3):225-37..
Leite A, Andrews N, Thomas S. 2017 Apr. Assessing recording delays in general practice records to inform near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD). Pharmacoepidemiol Drug Saf, 26(4):437-445.
Leite A, Andrews N, Thomas S. 2017 Feb 3. Assessing recording delays in general practice records to inform near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD). Pharmacoepidemiol Drug Saf, 26(4):437-445.
Leite A, Thomas SL, Andrews NJ. 2017 Dec 14. Implementing near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD). Vaccine, 35:6885-6892.
Leite A, Thomas SL, Andrews NJ. 2017 Nov 28. Do delays in data availability limit the implementation of near real-time vaccine safety surveillance using the Clinical Practice Research Datalink? Pharmacoepidemiol Drug Saf, 27(1):25-29.
Lemieux-Mellouki P, Drolet M, Jit M, Gingras G, Brisson M. 2017 Dec. Modelling multi-site transmission of the human papillomavirus and its impact on vaccination effectiveness. Epidemics, 21:80-87.
Li M, Taylor E, Atkins K, Chapman G, Galvani A. 2016 Jul 26. Stimulating Influenza Vaccination via Prosocial Motives. PLOS ONE, 11(7):e0159780.
Lin A, Ong K, Hobbelen P, King E, Mesher D, Edmunds W et al. 2017 Mar 1. Impact and cost-effectiveness of selective human papillomavirus vaccination of men who have sex with men. Clin Infect Dis, 64(5):580-588.
Luyten J, Bruynzeel L, van Hoek AJ. 2019 Apr 24. Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument.. Vaccine, Volume 37, Issue 18, Pages 2494-2501.
Luyten J, Kessels R, Atkins KE, Jit M, van Hoek AJ. 2019 May. Quantifying the public's view on social value judgments in vaccine decision-making: A discretechoice experiment.. Social Science and Medicine, 228:181-193.
Mbala P, Baguelin, M., Ngay, I., Rosello, A., Mulembakani, P., Demiris, N., Edmunds, W. J. & Muyembe, J.-J. 2017 May 26. Evaluating the frequency of asymptomatic Ebola virus infection. Philos Trans R Soc Lond B Biol Sci., 372(1721). pii: 20160303.
Mendes D, Mesher D, Pista A, Baguelin M, Jit M. 2018 Apr 1. Understanding differences in cervical cancer incidence in Western Europe: comparing Portugal and England. Eur J Public Health, 28(2):343-347.
Minassian C, Williams R, Meeraus WH, Smeeth L, Campbell OMR, Thomas SL. 2019 July. Methods to generate and validate a Pregnancy Register in the UK Clinical Practice Research Datalink primary care database.. Pharmacoepidemiol Drug Saf, 28(7):923-933.
Mounier-Jack S, Bell S, Chantler T, et al. 2020 Mar 30. Organisational factors affecting performance in delivering influenza vaccination to staff in NHS Acute Hospital Trusts in England: A qualitative study. Vaccine, 38(15):3079-3085.
Munday J, van Hoek A, Edmunds W, Atkins K. 2018 Sep 26. Quantifying the impact of social groups and vaccination on inequalities in infectious diseases using a mathematical model. BMC Medicine, 16(1).
Opatowski L, Baguelin M, Eggo R. 2018 Feb 15. Influenza interaction with cocirculating pathogens and its impact on surveillance, pathogenesis, and epidemic profile: A key role for mathematical modelling. PLoS Pathog, 14(2):e1006770.
Park M, Jit M, Wu JT. 2018 Sep 5. Cost-benefit analysis of vaccination: a comparative analysis of eight approaches for valuing changes to mortality and morbidity risks. BMC Med, 16(1):139..
Paterson P, Chantler T, Larson H. 2018 Aug 18. Reasons for non-vaccination: Parental vaccine hesitancy and the childhood influenza vaccination school pilot programme in England. Vaccine, 36(36):5397-5401.
Paterson P, Mounier-Jack S, Saliba V, Yarwood J, White J, Ramsay M, Chantler T. 2019 Jun 20. Strengthening HPV vaccination delivery: findings from a qualitative service evaluation of the adolescent girls' HPV vaccination programme in England. J Public Health (Oxf), pii: fdz061.
Paterson P, Schulz W, Utley M, Larson H. 2018 Mar 28. Parents’ Experience and Views of Vaccinating Their Child against Influenza at Primary School and at the General Practice. Int J Environ Res Public Health, 15(4). pii: E622.
Piot P, Coltart C, Atkins K. 2017 May 26. Preface: ‘The 2013–2016 West African Ebola epidemic: data, decision-making and disease control’. Philos Trans R Soc Lond B Biol Sci., 372(1721):20170020.
[*COVID-19] Prem K, Flasche S, et al. 2020 May 1. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study. Lancet Public Health, 5(5), e261 - e270.
Rosello A, Mossoko M, Flasche S, Van Hoek AJ, Mbala P, Camacho A, Funk S, Kucharski A, Ilunga BK, Edmunds WJ, Piot P, Baguelin M, Muyembe Tamfum JJ. 2015 Nov 3. Ebola virus disease in the Democratic Republic of the Congo, 1976-2014. Elife, 4. pii: e09015.
Sandmann F, Jit M, Robotham J, Deeny S. 2017 Sep. Burden, duration and costs of hospital bed closures due to acute gastroenteritis in England per winter, 2010/11–2015/16. J Hosp Infect, 97(1):79-85.
Sandmann F, Robotham J, Deeny S, Edmunds W, Jit M. 2018 Mar. Estimating the opportunity costs of bed-days. Health Econ, 27(3):592-605.
Sandmann F, Shallcross L, Adams N, Allen D, Coen P, Jeanes A et al. 2018 Aug 16. Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted Patients. Clin Infect Dis, 67(5):693-700.
Sandmann FG, Jit M, Robotham JV, Deeny SR. 2018 Sep. Revisiting the winter burden of acute gastroenteritis on hospital beds in England: change in data collection supports analytical method for previously missing values.. Journal of Hospital Infection, 100(1):115-117.
Sandmann F, Jit M, Andrews N, et al. 2020 Feb 25. Infant hospitalisations and fatalities averted by the maternal pertussis vaccination programme in England, 2012-2017, Post-implementation economic evaluation. Clinical Infectious Diseases, ciaa165.
Seok J, Heffernan C, Mounier-Jack S, Chantler T. 2018 Nov. Perspectives of vaccinators on the factors affecting uptake of meningococcal ACWY vaccine amongst school leavers in London.. Public Health, 164:128-133.
Southern J, Andrews N, Sandu P, Sheppard CL, Waight PA, Fry NK, van Hoek AJ, Miller E. 2018 May 25. Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England.. Plos One, 13(5): e0195799..
Taylor E, Atkins K, Medlock J, Li M, Chapman G, Galvani A. 2015 Jun 17. Cross-cultural household influence on vaccination decision. Med Decis Making, 36(7):844-53.
Thomas S, Walker J, Fenty J, Atkins K, Elliot A, Hughes H et al. 2017 Jan 23. Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted. Vaccine, 35(4):680-686.
Thorrington D, Andrews N, Stowe J, Miller E, van Hoek A. 2018 Feb 8. Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control. BMC Medicine, 16(1):13.
Thorrington D, Jit M, Eames K. 2015 Oct 5. Targeted vaccination in healthy school children - can primary school vaccination alone control influenza? Vaccine, 33(41):5415-5424.
Thorrington D, van Leeuwen E, Ramsay M, Pebody R, Baguelin M. 2017 Sep 8. Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England. BMC Medicine, 15(1): 166.
Thorrington D, van Rossum L, Knol M, de Melker H, Rümke H, Hak E et al. 2018 Feb 9. Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands. PLoS One, 13(2):e0192640.
van Hoek A, Campbell H, Amirthalingam G, Andrews N, Miller E. 2016 Jul. Cost-effectiveness and programmatic benefits of maternal vaccination against pertussis in England.. J Infect, 73(1):28-37.
van Hoek A.J., Miller E. 2016 Feb 25. Cost-effectiveness of vaccinating immunocompetent ≥65 year olds with the 13-valent pneumococcal conjugate vaccine in England. PLoS One, 11(2):e0149540.
van Kleef E, Deeny S, Jit M, Cookson B, Goldenberg S, Edmunds W et al. 2016 Nov 4. The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy. Vaccine, 34(46):5562-5570.
van Leeuwen E, Klepac P, Thorrington D, Pebody R, Baguelin M. 2017 Nov 20. fluEvidenceSynthesis: An R package for evidence synthesis based analysis of epidemiological outbreaks. PLoS Comput Biol, 13(11):e1005838.
Walker JL, Andrews NJ, Amirthalingam G, Forbes H, Langan SM, Thomas SL. 2018 Apr 19. Effectiveness of herpes zoster vaccination in an older United Kingdom population. Vaccine, 36: 2371–2377.
Walker JL, Andrews NJ, Atchison CJ, Collins S, Allen DJ, Ramsay ME, Ladhani SN, Thomas SL. 2019 Apr 11. Effectiveness of oral rotavirus vaccination in England against rotavirus-confirmed and all-cause acute gastroenteritis. Vaccine:X, 1:100005.
Walker JL, Andrews NJ, Mathur R, Smeeth L, Thomas SL. 2017 Oct. Trends in the burden of varicella in UK general practice. Epidemiol Infect, 145(13):2678-2682.
Wilson R, Larson H, Paterson P. 2016 Nov. Understanding factors influencing vaccination acceptance during pregnancy in Hackney, London. The Lancet, 388:S112.
Wilson R. J, Paterson P, Jarrett C, Larson H. 2015 Nov 25. Understanding factors infleuncing vaccination acceptance during pregnancy globally: A literature review. Vaccine, 33(47):6420-9.
Wilson RJ, Chantler T, Lees S, Paterson P, Larson H.. 2017 Aug 10. The patient-healthcare worker relationship: how does it affect patient views towards vaccination during pregnancy?. Research in the Sociology of Health Care, 35: 59-77.
Xiao X, van Hoek A, Kenward M, Melegaro A, Jit M. 2016 Dec. Clustering of contacts relevant to the spread of infectious disease. Epidemics, 17:1-9.
Yamin D, Atkins K, Remy V, Galvani A. 2016 Sept - Oct. Cost-Effectiveness of Rotavirus Vaccination in France—Accounting for Indirect Protection. Value Health, 19(6):811-819.